Choksi Laboratories Ltd
BSE:526546
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
41.46
88.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Choksi Laboratories Ltd
Cash & Cash Equivalents
Choksi Laboratories Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Choksi Laboratories Ltd
BSE:526546
|
Cash & Cash Equivalents
₹6.6m
|
CAGR 3-Years
29%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
L
|
L&T Technology Services Ltd
NSE:LTTS
|
Cash & Cash Equivalents
₹11.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Rudrabhishek Enterprises Ltd
NSE:REPL
|
Cash & Cash Equivalents
₹46.5m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
e
|
eMudhra Ltd
NSE:EMUDHRA
|
Cash & Cash Equivalents
₹2.3B
|
CAGR 3-Years
208%
|
CAGR 5-Years
149%
|
CAGR 10-Years
N/A
|
|
|
RITES Ltd
NSE:RITES
|
Cash & Cash Equivalents
₹31.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Latent View Analytics Ltd
NSE:LATENTVIEW
|
Cash & Cash Equivalents
₹1.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Choksi Laboratories Ltd
Glance View
Choksi Laboratories Ltd. engages in the business of research, development, and analytical testing. The company is headquartered in Indore, Madhya Pradesh. The firm operates through analytical testing. The company analyzes for its clients, or as regulatory requirement pharmaceuticals, food and agricultural products, construction materials, chemicals, calibration and environment monitoring services. The Company’s services include contract laboratory services, instrument calibration and validation services, environment management services, clinical research, consultancy, and assaying and hallmarking. Its contract laboratory services include pharmaceutical analysis, food and beverage analysis, water analysis and construction material analysis. The firm offers calibration services, including laboratory and on-site calibration for test equipment, process equipment and in many cases end-user equipment, plant shutdown calibration, and consultancy for setting up an in-house calibration laboratory.
See Also
What is Choksi Laboratories Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
6.6m
INR
Based on the financial report for Mar 31, 2024, Choksi Laboratories Ltd's Cash & Cash Equivalents amounts to 6.6m INR.
What is Choksi Laboratories Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
24%
Over the last year, the Cash & Cash Equivalents growth was 95%. The average annual Cash & Cash Equivalents growth rates for Choksi Laboratories Ltd have been 29% over the past three years , 24% over the past five years .
You don't have any saved screeners yet
